Skip to content
Biodatica
Start free

Investigator

Feixiong Cheng

CLEVELAND CLINIC LERNER COM-CWRU · funded by NIA

Companies
2

Resolved onto their grants.

Grants
9

Federal awards on file.

Non-dilutive funding
$6.4M

Summed across those awards.

First award
Sep 1, 2021

Latest Jun 1, 2025.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R01

    A Multimodal, Multiscale and Multistage Systems Biology (M3SB) Infrastructure for Precision Medicine in Alzheimer’s Disease and Longevity

    $802k

    Jun 1, 2025NIACLEVELAND CLINIC LERNER COM-CWRUNIH RePORTER · 11115357 (opens the source filing in a new tab)

  2. R01

    A Multimodal, Multiscale and Multistage Systems Biology (M3SB) Infrastructure for Precision Medicine in Alzheimer’s Disease and Longevity

    $787k

    Jun 1, 2025NIACLEVELAND CLINIC LERNER COM-CWRUNIH RePORTER · 11333258 (opens the source filing in a new tab)

  3. R01

    Microglial Activation and Inflammatory Endophenotypes Underlying Sex Differences of Alzheimer’s Disease

    $538k

    Sep 22, 2023NIACLEVELAND CLINIC LERNER COM-CWRUNIH RePORTER · 11088249 (opens the source filing in a new tab)

  4. R01

    Microglial Activation and Inflammatory Endophenotypes Underlying Sex Differences of Alzheimer’s Disease

    $549k

    Sep 22, 2023NIACLEVELAND CLINIC LERNER COM-CWRUNIH RePORTER · 11370110 (opens the source filing in a new tab)

  5. R01

    Characterize neuronal and glial cell-specific vulnerability to proteinopathies in Alzheimer's disease using multimodal single-nuclei genomic and epigenomic approaches

    $783k

    Sep 1, 2023NIACLEVELAND CLINIC LERNER COM-CWRUNIH RePORTER · 11092835 (opens the source filing in a new tab)

  6. R33

    Precision Medicine Digital Twins for Alzheimer’s Target and Drug Discovery and Longevity

    $552k

    Aug 15, 2023NIACLEVELAND CLINIC LERNER COM-CWRUNIH RePORTER · 11369213 (opens the source filing in a new tab)

  7. R01

    Alzheimer's Disease and Related Dementia-like Sequelae of SARS-CoV-2 Infection: Virus-Host Interactome, Neuropathobiology, and Drug Repurposing

    $781k

    May 15, 2023NIACLEVELAND CLINIC LERNER COM-CWRUNIH RePORTER · 11457086 (opens the source filing in a new tab)

  8. R01

    TREM2 Genotype-Informed Drug Repurposing and Combination Therapy Design for Alzheimer’s Disease

    $781k

    Jul 15, 2022NIACLEVELAND CLINIC LERNER COM-CWRUNIH RePORTER · 11075344 (opens the source filing in a new tab)

  9. U01

    Alzheimer's MultiOme Data Repurposing: Artificial Intelligence, Network Medicine, and Therapeutics Discovery

    $781k

    Sep 1, 2021NIACLEVELAND CLINIC LERNER COM-CWRUNIH RePORTER · 11176251 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources